Header Logo

Connection

CHRISTINA CHAPMAN to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications CHRISTINA CHAPMAN has written about Radiopharmaceuticals.
CHRISTINA CHAPMAN
Connection Strength
0.052
Radiopharmaceuticals
  1. Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024 Dec 01; 120(5):1332-1343.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.